Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.

Cejas P, Drier Y, Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Castillo CF, Ferrone CR, Adar T, Bowden M, Whitton HJ, Da Silva A, Font-Tello A, Long HW, Gaskell E, Shoresh N, Heaphy CM, Sicinska E, Kulke MH, Chung DC, Bernstein BE, Shivdasani RA.

Nat Med. 2019 Oct;25(10):1627. doi: 10.1038/s41591-019-0573-5.

PMID:
31501535
2.

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.

Cejas P, Drier Y, Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Castillo CF, Ferrone CR, Adar T, Bowden M, Whitton HJ, Da Silva A, Font-Tello A, Long HW, Gaskell E, Shoresh N, Heaphy CM, Sicinska E, Kulke MH, Chung DC, Bernstein BE, Shivdasani RA.

Nat Med. 2019 Aug;25(8):1260-1265. doi: 10.1038/s41591-019-0493-4. Epub 2019 Jul 1. Erratum in: Nat Med. 2019 Oct;25(10):1627.

PMID:
31263286
3.

Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.

Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M.

Gastroenterology. 2019 Sep;157(3):720-730.e2. doi: 10.1053/j.gastro.2019.05.014. Epub 2019 Jun 5.

PMID:
31175863
4.

Autoimmune Pancreatitis Type 2: Diagnostic Utility of PD-L1 Immunohistochemistry.

Gupta R, Neyaz A, Chougule A, Akita M, Zen Y, Forcione D, Castillo CF, Ferrone CR, Deshpande V.

Am J Surg Pathol. 2019 Jul;43(7):898-906. doi: 10.1097/PAS.0000000000001282.

PMID:
31135488
5.

Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.

Honselmann KC, Pergolini I, Castillo CF, Deshpande V, Ting D, Taylor MS, Bolm L, Qadan M, Wellner U, Sandini M, Bausch D, Warshaw AL, Lillemoe KD, Keck T, Ferrone CR.

Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003123. [Epub ahead of print]

PMID:
30672796
6.

Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).

Cai L, Michelakos T, Deshpande V, Arora KS, Yamada T, Ting DT, Taylor MS, Castillo CF, Warshaw AL, Lillemoe KD, Ferrone S, Ferrone CR.

Clin Cancer Res. 2019 Apr 15;25(8):2644-2655. doi: 10.1158/1078-0432.CCR-18-1401. Epub 2019 Jan 22.

7.

Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis.

Malleo G, Maggino L, Ferrone CR, Marchegiani G, Warshaw AL, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003083. [Epub ahead of print]

PMID:
30339622
8.

Understanding Pancreatic Diseases Using Animated Pancreas Patient: Informing Patients for Better Health Outcomes With Visual Formats of Learning.

Munigala S, Gardner TB, OʼReilly EM, Castillo CF, Ko AH, Pleskow D, Mills JB, Vollmer CM Jr, Searle NA, Alsante M, Holt JM, Gelrud A.

Pancreas. 2018 Nov/Dec;47(10):1256-1261. doi: 10.1097/MPA.0000000000001178.

PMID:
30286013
9.

Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer.

Sandini M, Ruscic KJ, Ferrone CR, Qadan M, Eikermann M, Warshaw AL, Lillemoe KD, Castillo CF.

J Gastrointest Surg. 2019 Oct;23(10):1984-1990. doi: 10.1007/s11605-018-3939-y. Epub 2018 Sep 17.

PMID:
30225794
10.

Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.

Patra KC, Kato Y, Mizukami Y, Widholz S, Boukhali M, Revenco I, Grossman EA, Ji F, Sadreyev RI, Liss AS, Screaton RA, Sakamoto K, Ryan DP, Mino-Kenudson M, Castillo CF, Nomura DK, Haas W, Bardeesy N.

Nat Cell Biol. 2018 Jul;20(7):811-822. doi: 10.1038/s41556-018-0122-3. Epub 2018 Jun 25.

11.

To resect or not to resect: a review of pancreatic cyst disease management.

Harrison JM, Castillo CF.

Curr Opin Gastroenterol. 2018 Sep;34(5):343-348. doi: 10.1097/MOG.0000000000000463. Review.

PMID:
29912020
12.

Seven Salmonella Typhimurium Outbreaks in Australia Linked by Trace-Back and Whole Genome Sequencing.

Ford L, Wang Q, Stafford R, Ressler KA, Norton S, Shadbolt C, Hope K, Franklin N, Krsteski R, Carswell A, Carter GP, Seemann T, Howard P, Valcanis M, Castillo CFS, Bates J, Glass K, Williamson DA, Sintchenko V, Howden BP, Kirk MD.

Foodborne Pathog Dis. 2018 May;15(5):285-292. doi: 10.1089/fpd.2017.2353. Epub 2018 Mar 20.

PMID:
29638170
13.

A Changing Landscape in Pancreatic Cancer.

Castillo CFF.

Ann Surg. 2018 Jul;268(1):9-10. doi: 10.1097/SLA.0000000000002755. No abstract available.

PMID:
29578913
14.

Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer.

Sell NM, Fong ZV, Del Castillo CF, Qadan M, Warshaw AL, Chang D, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2018 Apr;25(4):1009-1016. doi: 10.1245/s10434-017-6317-1. Epub 2018 Jan 31.

PMID:
29388123
15.

Incorporating Whole-Genome Sequencing into Public Health Surveillance: Lessons from Prospective Sequencing of Salmonella Typhimurium in Australia.

Ford L, Carter GP, Wang Q, Seemann T, Sintchenko V, Glass K, Williamson DA, Howard P, Valcanis M, Castillo CFS, Sait M, Howden BP, Kirk MD.

Foodborne Pathog Dis. 2018 Mar;15(3):161-167. doi: 10.1089/fpd.2017.2352. Epub 2018 Jan 16.

PMID:
29336594
16.

Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.

Michelakos T, Pergolini I, Castillo CF, Honselmann KC, Cai L, Deshpande V, Wo JY, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Nipp RD, Parikh A, Qadan M, Warshaw AL, Hong TS, Lillemoe KD, Ferrone CR.

Ann Surg. 2019 Apr;269(4):733-740. doi: 10.1097/SLA.0000000000002600.

PMID:
29227344
17.

Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.

Ecker BL, McMillan MT, Maggino L, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Salem RR, Soares KC, Valero V 3rd, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

J Gastrointest Surg. 2018 Jan;22(1):68-76. doi: 10.1007/s11605-017-3547-2. Epub 2017 Aug 24. No abstract available.

PMID:
28840459
18.

Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.

van Brunschot S, Hollemans RA, Bakker OJ, Besselink MG, Baron TH, Beger HG, Boermeester MA, Bollen TL, Bruno MJ, Carter R, French JJ, Coelho D, Dahl B, Dijkgraaf MG, Doctor N, Fagenholz PJ, Farkas G, Castillo CFD, Fockens P, Freeman ML, Gardner TB, Goor HV, Gooszen HG, Hannink G, Lochan R, McKay CJ, Neoptolemos JP, Oláh A, Parks RW, Peev MP, Raraty M, Rau B, Rösch T, Rovers M, Seifert H, Siriwardena AK, Horvath KD, van Santvoort HC.

Gut. 2018 Apr;67(4):697-706. doi: 10.1136/gutjnl-2016-313341. Epub 2017 Aug 3.

19.

Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Aug;268(2):340-347. doi: 10.1097/SLA.0000000000002421.

20.

Health-related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy.

Fong ZV, Alvino DM, Castillo CF, Nipp RD, Traeger LN, Ruddy M, Lubitz CC, Johnson CD, Chang DC, Warshaw AL, Lillemoe KD, Ferrone CR.

Ann Surg. 2017 Oct;266(4):685-692. doi: 10.1097/SLA.0000000000002380.

PMID:
28657944
21.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
22.

Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.

Yang KS, Im H, Hong S, Pergolini I, Del Castillo AF, Wang R, Clardy S, Huang CH, Pille C, Ferrone S, Yang R, Castro CM, Lee H, Del Castillo CF, Weissleder R.

Sci Transl Med. 2017 May 24;9(391). pii: eaal3226. doi: 10.1126/scitranslmed.aal3226.

23.

Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch-duct IPMN After 10 Years of Surveillance.

Honselmann KC, Patino M, Mino-Kenudson M, Ferrone C, Warshaw AL, Castillo CF, Lillemoe KD.

Ann Surg. 2017 Dec;266(6):e38-e40. doi: 10.1097/SLA.0000000000002238. No abstract available.

PMID:
28338512
24.

Cytologic characteristics of circulating epithelioid cells in pancreatic disease.

Rosenbaum MW, Cauley CE, Kulemann B, Liss AS, Castillo CF, Warshaw AL, Lillemoe KD, Thayer SP, Pitman MB.

Cancer Cytopathol. 2017 May;125(5):332-340. doi: 10.1002/cncy.21841. Epub 2017 Mar 3.

25.

Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence.

Marchegiani G, Andrianello S, Massignani M, Malleo G, Maggino L, Paiella S, Ferrone CR, Luchini C, Scarpa A, Capelli P, Mino-Kenudson M, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

J Surg Oncol. 2016 Oct;114(5):597-601. doi: 10.1002/jso.24380. Epub 2016 Jul 29.

PMID:
27471041
26.

Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM.

Marchegiani G, Andrianello S, Malleo G, De Gregorio L, Scarpa A, Mino-Kenudson M, Maggino L, Ferrone CR, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

Ann Surg. 2017 Jul;266(1):142-148. doi: 10.1097/SLA.0000000000001837.

PMID:
27322188
27.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gönen M, Klimstra DS, Mino-Kenudson M.

Ann Surg. 2017 Jan;265(1):185-191. doi: 10.1097/SLA.0000000000001763.

28.

Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis.

Crippa S, Capurso G, Cammà C, Fave GD, Castillo CF, Falconi M.

Dig Liver Dis. 2016 May;48(5):473-479. doi: 10.1016/j.dld.2016.02.003. Epub 2016 Feb 18. Review.

PMID:
26965783
29.

Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.

Deshpande V, Konstantinidis IT, Castillo CF, Hezel AF, Haigis KM, Ting DT, Bardeesy N, Goyal L, Zhu AX, Warshaw AL, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2016 May;20(5):953-9. doi: 10.1007/s11605-016-3108-0. Epub 2016 Mar 8.

PMID:
26956004
30.

Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation.

McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Miller BC, Salem RR, Soares K, Valero V, Wolfgang CL, Vollmer CM Jr.

Ann Surg. 2016 Aug;264(2):344-52. doi: 10.1097/SLA.0000000000001537.

PMID:
26727086
31.
32.

The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy.

McMillan MT, Vollmer CM Jr, Asbun HJ, Ball CG, Bassi C, Beane JD, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares K, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Behrman SW.

J Gastrointest Surg. 2016 Feb;20(2):262-76. doi: 10.1007/s11605-015-2884-2. Epub 2015 Jul 11.

PMID:
26162925
33.

Quality assessment of the guidelines on cystic neoplasms of the pancreas.

Falconi M, Crippa S, Chari S, Conlon K, Kim SW, Levy P, Tanaka M, Werner J, Wolfgang CL, Pezzilli R, Castillo CF.

Pancreatology. 2015 Sep-Oct;15(5):463-469. doi: 10.1016/j.pan.2015.05.478. Epub 2015 Jun 12. Review.

PMID:
26100659
34.

Pancreatic duct glands (PDGs) are a progenitor compartment responsible for pancreatic ductal epithelial repair.

Yamaguchi J, Liss AS, Sontheimer A, Mino-Kenudson M, Castillo CF, Warshaw AL, Thayer SP.

Stem Cell Res. 2015 Jul;15(1):190-202. doi: 10.1016/j.scr.2015.05.006. Epub 2015 May 19.

35.

Patterns of Recurrence After Resection of IPMN: Who, When, and How?

Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Castillo CF.

Ann Surg. 2015 Dec;262(6):1108-14. doi: 10.1097/SLA.0000000000001008.

PMID:
25793719
36.

Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines.

Pitman MB, Centeno BA, Ali SZ, Genevay M, Stelow E, Mino-Kenudson M, Castillo CF, Schmidt CM, Brugge WR, Layfield LJ.

Cytojournal. 2014 Jun 2;11(Suppl 1):3. doi: 10.4103/1742-6413.133343. eCollection 2014.

37.

[Gynecology and obstetrics].

del Castillo CF.

Ginecol Obstet Mex. 2014 Jul;82(7):2 p preceding 441. Spanish. No abstract available.

PMID:
25102668
38.
39.

[Ginecología y Obstetricia de México].

del Castillo CF.

Ginecol Obstet Mex. 2014 Apr;82(4):6 p preceding 223. Spanish. No abstract available.

PMID:
24881354
40.

A method for fixing and paraffin embedding tissue to retain the natural fluorescence of reporter proteins.

Nakagawa A, Alt KV, Lillemoe KD, Castillo CF, Warshaw AL, Liss AS.

Biotechniques. 2015 Sep 1;59(3):153-5. doi: 10.2144/000114328. eCollection 2015 Sep.

41.

Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida.

Liddle RA, Freeman M, Simeone DM, Saluja AK, Castillo CF, Maitra A, Pandol SJ, Go VL.

Pancreas. 2013 Nov;42(8):1333-4. doi: 10.1097/MPA.0b013e3182a99936. No abstract available.

42.

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.

Ann Surg. 2013 Apr;257(4):731-6. doi: 10.1097/SLA.0b013e318263da2f.

PMID:
22968073
43.

Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?

Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF.

Pancreatology. 2012 Jul-Aug;12(4):358-63. doi: 10.1016/j.pan.2012.05.011. Epub 2012 Jun 15. Review.

44.

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN, Cheuk W, Cornell L, Castillo CF, Ferry JA, Forcione D, Klöppel G, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani D, Sato Y, Smyrk T, Stone JR, Takahira M, Umehara H, Webster G, Yamamoto M, Yi E, Yoshino T, Zamboni G, Zen Y, Chari S.

Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593. No abstract available.

45.

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.

Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, Castillo CF, Sahani D, Bounds B, Forcione D, Brugge WR, Pitman MB.

Ann Surg. 2011 Dec;254(6):977-83. doi: 10.1097/SLA.0b013e3182383118.

46.

Interventional radiology in the management of abdominal collections after distal pancreatectomy: a retrospective review.

Cronin CG, Gervais DA, Castillo CF, Mueller PR, Arellano RS.

AJR Am J Roentgenol. 2011 Jul;197(1):241-6. doi: 10.2214/AJR.10.5447. Review.

PMID:
21701036
47.

[Gynecology and obstetrics in Mexico].

del Castillo CF.

Ginecol Obstet Mex. 2009 Nov;77(11):497. Spanish. No abstract available.

PMID:
20085131
48.

Cystic pancreatic lesions: classification and management.

Sahani DV, Miller JC, del Castillo CF, Brugge WR, Thrall JH, Lee SI.

J Am Coll Radiol. 2009 May;6(5):376-80. doi: 10.1016/j.jacr.2008.10.004. Review. No abstract available.

PMID:
19394581
49.

Distal biliary malignancy.

Veillette G, Castillo CF.

Surg Clin North Am. 2008 Dec;88(6):1429-47, xi. doi: 10.1016/j.suc.2008.07.003. Review.

PMID:
18992603
50.

Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.

Crippa S, Salvia R, Warshaw AL, Domínguez I, Bassi C, Falconi M, Thayer SP, Zamboni G, Lauwers GY, Mino-Kenudson M, Capelli P, Pederzoli P, Castillo CF.

Ann Surg. 2008 Apr;247(4):571-9. doi: 10.1097/SLA.0b013e31811f4449.

Supplemental Content

Loading ...
Support Center